Thermo Fisher's proposal to acquire Clario Holdings to be reviewed in Australia
MLex Summary: The US-based life sciences company Thermo Fisher Scientific’s bid to acquire clinical-trial technology provider Clario Holdings will be reviewed by Australia’s competition regulator. In a statement on Tuesday, the...To view the full article, register now.
Already a subscriber? Click here to view full article